OliX PharmaceuticalsInc (226950) — Financial Flexibility Index
OliX PharmaceuticalsInc (226950) has a Financial Flexibility Index of -0.13x as of March 2026. Free cash flow of ₩-5.17 Billion (operating CF ₩-5.72 Billion minus capex ₩548.52 Million) represents 0% of total liabilities (₩40.96 Billion). Check OliX PharmaceuticalsInc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
OliX PharmaceuticalsInc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for OliX PharmaceuticalsInc across 10 annual periods. For the full cash flow conversion analysis, see cash flow conversion of OliX PharmaceuticalsInc.
Annual Financial Flexibility Index for OliX PharmaceuticalsInc (2016–2025)
Year-by-year free cash flow to debt coverage for OliX PharmaceuticalsInc. Explore 226950 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.31x | ₩-14.04 Billion | ₩-15.90 Billion | ₩45.29 Billion | ▼ -18.6% |
| 2024 | -0.26x | ₩-13.97 Billion | ₩-28.04 Billion | ₩53.40 Billion | ▼ -13.4% |
| 2023 | -0.23x | ₩-12.10 Billion | ₩-21.17 Billion | ₩52.49 Billion | ▲ +45.9% |
| 2022 | -0.43x | ₩-28.45 Billion | ₩-30.68 Billion | ₩66.74 Billion | ▼ -63.5% |
| 2021 | -0.26x | ₩-17.76 Billion | ₩-19.05 Billion | ₩68.15 Billion | ▼ -191.9% |
| 2020 | -0.09x | ₩-2.97 Billion | ₩-3.76 Billion | ₩33.29 Billion | ▲ +96.9% |
| 2019 | -2.85x | ₩-9.73 Billion | ₩-10.73 Billion | ₩3.41 Billion | ▲ +74.6% |
| 2018 | -11.24x | ₩-7.86 Billion | ₩-8.36 Billion | ₩698.94 Million | ▼ -845.8% |
| 2017 | -1.19x | ₩-3.52 Billion | ₩-4.79 Billion | ₩2.96 Billion | ▼ -1649.6% |
| 2016 | -0.07x | ₩-176.12 Million | ₩-3.45 Billion | ₩2.59 Billion | — |